Bioharvest Sciences (BHST) Notes Payables (2023 - 2025)

Bioharvest Sciences' Notes Payables history runs 3 years deep, the most recent figure standing at $149000.0 for Q4 2025.

• On a quarterly basis, Notes Payables fell 96.18% year-over-year to $149000.0 in Q4 2025; TTM through Dec 2025 was $149000.0, a 96.18% decrease from a year earlier, with the FY2025 full-year figure at $149000.0, down 96.18% from the prior year.
• Notes Payables declined to $149000.0 in Q4 2025 per BHST's latest filing, from $3.9 million in the prior quarter.
• Across five years, Notes Payables topped out at $3.9 million in Q4 2024 and bottomed at $149000.0 in Q4 2025.
• The 3-year median for Notes Payables is $526000.0 (2023), against an average of $1.5 million.
• Across the five-year window, Notes Payables soared 642.4% in 2024 and tumbled 96.18% in 2025, its largest moves.
• Year by year, Notes Payables stood at $526000.0 in 2023, then surged by 642.4% to $3.9 million in 2024, then tumbled by 96.18% to $149000.0 in 2025.
• Per Business Quant, the three latest BHST Notes Payables figures stand at $149000.0 (Q4 2025), $3.9 million (Q4 2024), and $526000.0 (Q4 2023).